SecBot SecBot

Alternatives to PAIN Act

H.R. 7142 Rep. Mariannette Miller-Meeks (R-IA-1) In committee
Bill text PDF
  1. Introduced Jan 30
  2. Committee Jan 30
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jan 30, 2024Next: House vote
680d ago Dec 17, 2024: Referred to the Subcommittee on Health.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 9 filings
Subscribe to see spend
Member trades
2trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Biotech & Pharma 1
Search all 1 companies, their asks and price moves Subscribe

Summary

This bill amends Medicare Part D to improve access to non-opioid pain management drugs by reducing patient costs and removing certain insurance barriers. It applies to drugs approved by the FDA for acute or postoperative pain that do not act on opioid receptors and are not controlled substances. The changes take effect for plan years starting on or after January 1, 2025.

Sec. 2, Appropriate cost-sharing for qualifying non-opioid pain management drugs under Medicare Part D: For these drugs, the Part D deductible does not apply, and the drug must be placed on the lowest cost-sharing tier. For low-income individuals, no deductible or cost-sharing applies for these drugs.

Sec. 3, Prohibition on the use of step therapy and prior authorization for qualifying non-opioid pain management drugs under Medicare Part D: A prescription drug plan cannot require a patient to try an opioid first (step therapy) or get prior approval before covering a qualifying non-opioid pain management drug.

Sec. 4, Rule of construction: Nothing in this bill limits a health care provider's authority to prescribe any legally marketed drug for a patient's condition.

Summary of the bill text as introduced in House (Jan 30, 2024), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.